Study identifier:NIS-CRU-ATC-2011/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Observational non-interventional study – epidemiological survey “AchievemenT of goal resting HEart rate on beta-blockers in patients with stable angiNA and hypertension in routine practice"
Stable Angina
-
No
-
All
400
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
This is a multicenter survey of Russian data on target heart rate achievement in patients with stable angina and arterial hypertension who are currently treated with beta-blockers for at least 2 months and with no dose change for a minimum of 4 weeks
Location
Location
Ekaterinburg, Russian Federation
Location
Moscow, Russian Federation
Location
Rostov-on-Don, Russian Federation
Location
Saratov, Russian Federation
Location
St.Petersburg, Russian Federation
Location
Ulyanovsk, Russian Federation
Arms | Assigned Interventions |
---|---|
achieving resting HR goals Patient population will be comprised of typical for cardiological practice sample of patients with Coronary Heart Disease and arterial hypertension administered beta-blockers, subjects achieving resting HR goals, according to ACC/AHA/ACP-ASIM Guidelines | - |
non-achieving HR goals Patient population will be comprised of typical for cardiological practice sample of patients with Coronary Heart Disease and arterial hypertension administered beta-blockers, subjects non-achieving HR goals, according to ACC/AHA/ACP-ASIM Guidelines | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.